Zoetis Inc (Z1TS34)

Currency in BRL
23.04
-1.59(-6.46%)
Closed·
Trading near 52-week Low
Z1TS34 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
22.9524.28
52 wk Range
22.9553.75
Key Statistics
Bid/Ask
22.19 / 26.25
Prev. Close
24.63
Open
24.18
Day's Range
22.95-24.28
52 wk Range
22.95-53.75
Volume
4.37K
Average Volume (3m)
7K
1-Year Change
-54.1948%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
Z1TS34 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Zoetis Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
May 07, 2026
EPS / Forecast
1.42 / --
Revenue / Forecast
2.26B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.13%
Dividend Yield
1.83%
Industry Median 2.16%
Annualized payout
0.45
Paid quarterly
5-Years Growth
+19.02%
Growth Streak

Z1TS34 Income Statement

Compare Z1TS34 to Peers and Sector

Metrics to compare
Z1TS34
Peers
Sector
Relationship
P/E Ratio
11.4x14.9x−0.4x
PEG Ratio
1.830.030.00
Price/Book
9.5x2.2x2.6x
Price / LTM Sales
3.2x2.3x3.0x
Upside (Analyst Target)
-16.2%48.7%
Fair Value Upside
Unlock−4.4%5.6%Unlock

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.

Employees
14500
Market
Brazil

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
203.05M48.43%4.68B
Other Institutional Investors
211.38M50.42%4.87B
Public Companies & Retail Investors
4.80M1.15%110.63M
Total
419.23M100.00%9.66B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.8.98%37,660,315867,694
Vanguard Capital Management, LLC6.79%28,468,256655,909

People Also Watch

21.67
CYRE3
-0.73%
21.60
HYPE3
+1.27%
17.49
MDIA3
+0.63%
3.73
GMAT3
-2.36%

FAQ

What Is the Zoetis (Z1TS34) Stock Price Today?

The Zoetis stock price today is 23.04 BRL.

What Stock Exchange Does Zoetis Trade On?

Zoetis is listed and trades on the B3 Stock Exchange.

What Is the Stock Symbol for Zoetis?

The stock symbol for Zoetis is "Z1TS34."

Does Zoetis Pay Dividends? What’s The Current Dividend Yield?

The Zoetis dividend yield is 1.96%.

What Is the Zoetis Market Cap?

As of today, Zoetis market cap is 164.60B BRL.

What Is Zoetis's Earnings Per Share (TTM)?

The Zoetis EPS (TTM) is 6.13.

From a Technical Analysis Perspective, Is Z1TS34 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Zoetis Stock Split?

Zoetis has split 1 times.

How Many Employees Does Zoetis Have?

Zoetis has 14500 employees.

What is the current trading status of Zoetis (Z1TS34)?

As of Aug 08, 2026, Zoetis (Z1TS34) is trading at a price of 23.04 BRL, with a previous close of 24.63 BRL. The stock has fluctuated within a day range of 22.95 BRL to 24.28 BRL, while its 52-week range spans from 22.95 BRL to 53.75 BRL.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.